Health Blueprint

Back to Longevity News

News summary

Consumption, Expenditure, and Treatment Gap of Anti-Osteoporosis Medications in China: A nationwide analysis from 2019 to 2024

Source: Frontiers - Health • Published: 31 Oct 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Nationwide hospital procurement data (2019–2024) found a large osteoporosis treatment shortfall.

Consumption, Expenditure, and Treatment Gap of Anti-Osteoporosis Medications in China: A nationwide analysis from 2019 to 2024
Key Takeaways
  • Hospital procurement data show ongoing under-treatment of osteoporosis.
  • Hospital-only estimates were found to underestimate national AOM use.
  • DDD/DID analysis showed a substantial treatment gap versus need.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickLongevity is leaving the clinicStephen Watson argues that hotels, gyms and residential communities can build longevity memberships around the relationships they already have.